Confirmed Invited Speakers

A distinguished panel of world-renowned speakers have already confirmed their participation to the CLEPSO Meeting 2018:

 

 

Lucia ALTUCCI, University of Naples, Naples, Italy

From Single-Target to Multi-Target Epigenetic Therapeutics

 

Jesper Boje ANDERSEN, Univesity of Copenhagen, Copenhagen, Denmark

Epigenetics of Cholangiocarcinoma

 

Vim Van Den BERGHE, University of Antwerp, Belgium

BRCA Methylation Changes in Cancer and Cardiovascular Disease

 

Fabio COPPEDÈ, University of Pisa, Pisa, Italy

Pharmacoepigenetics and Pharmacoepigenomics of GastrointestinalCancers

 

Jim DAVIE, University of Manitoba, Winnipeg, Canada

Epigenetic Profiling of Fetal Alcohol Syndrome and Type II Diabetes

 

James D. FLANAGAN, Imperial College of London, London, UK

Epigenome-Wide Association Studies for Breast Cancer Risk and Risk Factors.

 

Kirsten Grønbæk, Copenhagen Biocenter, Copenhagen, Denmark

Modulation of the Immune System by Epigenetic Therapy

 

Christian HEDRICH, University of Liverpool, Liverpool, UK

On the Epigenetics of Systemic Lupus Erythematosus

 

Sam KEATING, Radboud Center for Infectious Diseases, Nijmegen, The Netherlands

Epigenetics and the Immune System

 

Vessela N. KRISTENSEN, University of Oslo, Oslo, Norway

DNA Methylation at Enhancers Identifies Distinct Breast Cancer Lineages.

 

Jonathan LICHT, University of Florida, Gainesville, FL, USA

Epigenetic Dysregulation in Lymphoid Malignancy

 

Charlotte LING, University of Lund, Malmö, Sweden

The Effects of High Glucose Exposure on Global Gene Expression and DNA Methylation in Human Pancreatic Islets.

 

Janos MINAROVITS, University of Szeged, Szeged, Hungary

Epigenetic Dysregulation Through Infectious Disease

 

Pamela MUNSTER, University of California, San Francisco CA, USA

Select HDAC Enzyme Expression as Aost Specific Biomarkers

 

Arpad PATAI, Semmelweis University, Budapest, Hungary

Clinical Implications of DNA Methylation in Inflammatory Bowel Disease, Colorectal Polyps and Cancer

 

Gerd PFEIFER, Cancer for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA

Oxidation of 5-Methylcytosine in Development and Disease

 

Edyta RESZKA, Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Diseases, Lodz, Poland

Circadian Gene Variants and Breast Cancer.

 

Bart P.F. RUTTEN, Maastricht University Medical Centre, Maastricht, the Netherlands

The Epigenetics of Aging and Neurodegeneration

 

David S. SCHRUMP, NIH, Bethesda, MD, USA

Epigenetics of Malignant Pleural Mesothelioma

 

Anton SHOSTAK, University of Heidelberg, Heidelberg, Germany

Circadian Clock, Cell Division, and Cancer: From Molecules to Organism.

 

Alessio SQUASSINA, University of Cagliari, Cagliari, Italy

Recent Trends on the Role of Epigenomics, Metabolomics and Noncoding RNAs in Rationalizing Mood Stabilizing Treatment

 

Henk STUNNENBERG, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands

The Interplay of Epigenetic Marks During Stem Cell Differentiation and Development.